[PRESS RELEASE] – NEUMÜNSTER, Germany, March 11, 2025 – Tilray Medical, a division of Tilray Brands Inc. and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and health care practitioners to make informed individualized health decisions, transforming health care, announced the introduction of Tilray Craft, a brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany.
Tilray Craft is being introduced to address the evolving needs of patients in Germany for flower-based medical cannabis. The brand aims to offer unique flower options that are not currently available in the market, particularly targeting patients who require medical cannabis flower with higher THC and higher terpene content derived from novel genetic lineages. The latest product introduced under the Tilray Craft brand is Cannabisblüten THC 25 TAM.
Product details for Tilray Craft, Cannabisblüten THC 25 TAM, include:
- Strain: Triangle Mints
- Terpene Content: 2.9%
- Type: Sativa-leaning hybrid
- Genetics: Cross of Triangle Kush and Animal Mints
- Flavor Profile: Herbal, spicy, and earthy with diesel undertones
Denise Faltischek, chief strategy officer and head of International at Tilray Brands, said, "Our commitment to innovation in medical cannabis, alongside our unwavering dedication to patient care, guides our every endeavor. The launch of Tilray Craft and our new genetics, highlights our efforts to provide patients and healthcare professionals with high-quality, effective, and safe medical cannabis products. We continually assess our portfolio in collaboration with healthcare providers to address the evolving needs of our patients globally."
Tilray Craft's medical cannabis products, including the Tilray Craft, Cannabisblüten THC 25 TAM, are now available across Germany with a physician's prescription at pharmacies.
